Gainers
Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal epithelial defect.
Elys Game Technology Corp (NASDAQ: ELYS) shares are trading higher by 118.44% to $0.38 during Tuesday's session after the company and Cloakbook were granted a license to commence sportsbook operations in Washington, D.C.
Elys Game Technology Corp (NASDAQ:ELYS) and the Cloakbook LLC secure a License to commence sportsbook operations in Washington D.C. Cloakbook, a joint venture…